BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Deals

  QUATRx Pharmaceuticals Files For $86.25 Million IPO

  February 6, 2006

   · 

  1 min read
• Drug Development

  Arrow Therapeutics Ltd. Selects Hepatitis C Clinical Candidate

  February 6, 2006

   · 

  1 min read
• Business

  Telik, Inc. Announces Quarterly Financial Release, Conference Call And Webcast

  February 6, 2006

   · 

  1 min read
• BioForest

  Calypte Biomedical Corporation Notified By The AMEX

  February 6, 2006

   · 

  4 min read
• FDA

  Mylan Laboratories Inc. Announces FDA Approval For Cyclobenzaprine Hydrochloride Tablets USP, 5Mg

  February 6, 2006

   · 

  1 min read
• Drug Development

  Celtic Pharma And Neurobiological Technologies, Inc. Announce Initiation Of Second Pivotal Phase III Clinical Trial For XERECEPT(R), A Therapy For Peritumoral Brain Edema

  February 6, 2006

   · 

  3 min read
• Business

  GlaxoSmithKline Opens Australian Relenza Plant

  February 6, 2006

   · 

  1 min read
• BioCapital

  Martek Biosciences Corporation Renews Stockholder Rights Plan

  February 6, 2006

   · 

  2 min read
• Drug Development

  ReNeuron Announces Further Positive Pre-Clinical Efficacy Data With ReN001 Stem Cell Therapy For Stroke

  February 6, 2006

   · 

  1 min read
• Drug Development

  PRANA Biotechnology Release: PBT2 Successfully Completes Initial Phase I Clinical Trial

  February 6, 2006

   · 

  1 min read